🔎 Trials Near Me

Home › Facioscapulohumeral Muscular Dystrophy

Facioscapulohumeral Muscular Dystrophy clinical trials recruiting in the U.S.

7 studies for Facioscapulohumeral Muscular Dystrophy are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

Biomarker Development for Muscular Dystrophies

RecruitingObservational studyHealthy volunteers welcome
Ages 5 and older · All sexes · Updated Oct 29, 2026 · NCT05019625

Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD)

RecruitingPhase 1
Ages 15 and older · All sexes · Updated Oct 21, 2026 · NCT07086521

Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD

RecruitingPhase 2
Ages 18 to 60 · All sexes · Updated Sep 2, 2026 · NCT07435129

Clenbuterol to Target DUX4 in FSHD

RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Feb 25, 2026 · NCT06721299

Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)

RecruitingObservational study
Ages 5 to 17 · All sexes · Updated Feb 25, 2026 · NCT06847282

BetterLife FSHD: A Patient-driven Health and Research Platform

RecruitingObservational study
Ages 1 and older · All sexes · Updated Feb 20, 2026 · NCT07409142

Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry

RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Oct 15, 2025 · NCT00082108

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.